Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - OtherRevenue (Gross)
Ratios

Abeona Therapeutics (ABEO) Accumulated Depreciation & Amortization: 2011-2025

Historic Accumulated Depreciation & Amortization for Abeona Therapeutics (ABEO) over the last 6 years, with Sep 2025 value amounting to $600,000.

  • Abeona Therapeutics' Accumulated Depreciation & Amortization rose 20.00% to $600,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year increase of 10.00%. This contributed to the annual value of $2.0 million for FY2024, which is 13.04% down from last year.
  • As of Q3 2025, Abeona Therapeutics' Accumulated Depreciation & Amortization stood at $600,000, which was down 0.00% from $600,000 recorded in Q2 2025.
  • In the past 5 years, Abeona Therapeutics' Accumulated Depreciation & Amortization registered a high of $900,000 during Q4 2021, and its lowest value of $500,000 during Q3 2023.
  • For the 3-year period, Abeona Therapeutics' Accumulated Depreciation & Amortization averaged around $545,455, with its median value being $500,000 (2025).
  • In the last 5 years, Abeona Therapeutics' Accumulated Depreciation & Amortization plummeted by 87.72% in 2021 and then increased by 20.00% in 2025.
  • Over the past 5 years, Abeona Therapeutics' Accumulated Depreciation & Amortization (Quarterly) stood at $900,000 in 2021, then declined by 11.11% to $800,000 in 2022, then crashed by 37.50% to $500,000 in 2023, then remained steady at $500,000 in 2024, then rose by 20.00% to $600,000 in 2025.
  • Its last three reported values are $600,000 in Q3 2025, $600,000 for Q2 2025, and $500,000 during Q1 2025.